Organisation paid for research Program year 2021 Source: CMS Open Payments

Waldron Medical Research & Developm Ent LLC

Neither a doctor nor a teaching hospital

Research payments

$16,914

2 payments

Through program year 2021, Waldron Medical Research & Developm Ent LLC is reported as receiving $16,914 in research payments, across 2 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2021	Research	$4,675	1
2019	Research	$12,239	1

Breakdown

Who paid Research payments · program years 2019–2021

Janssen Research & Development, LLC $16,914 2 payments

Studies the money was for Research payments · program years 2019–2021

A Phase 2 Study of Daratumumab Subcutaneous (Dara-SC) Administration in Combination with Carfilzomib and Dexamethasone (DKd) Compared with Carfilzomib and Dexamethasone (Kd) in Participants with Multiple Myeloma who have been Previously Treated with Daratumumab Intravenous (Dara-IV) to Evaluate Daratumumab Retreatment $12,239 1 payment
A Phase 2 Study of Daratumumab Subcutaneous Dara SC Administration in Combination with Carfilzomib and Dexamethasone DKd Compared with Carfilzomib and Dexamethasone Kd in Participants with Multiple Myeloma who have been Previously Treated with Daratumumab $4,675 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.